Medisun PDT 9000
Call for Price
Medisun PDT 9000 is an innovative light treatment system for the painless exposure of photodynamic therapy (PDT) with polychromatic spectra from a high power LED light source.
The main indications are actinic keratoses, which are reported for a steady increase worldwide. Actinic keratoses are a preliminary stage to skin cancer, usually associated with excessive exposure to the sun during life, e.g. in outdoor occupations.
Therefore, the workmen`s compensation boards in Germany have recognized actinic keratosis as an occupational disease for many professions. Patients in these cases have a lifelong right to get paid the treatment costs.
Conventional red light PDT has been established for many years as it has proven to be very effective. However, the therapy protocols used are usually associated with great pain for the patients.
With the outdoor daylight PDT with natural sunlight, an alternative therapy protocol has been developed that contains all wavelengths of light and is less painful. However, the actual irradiance and the spectral composition of the light will depend on some uncontrollable factors such as the season, time of day, temperature, elevation above sea level, geographical location and weather conditions.
In certain weather conditions, e.g. below + 10 ° C, the outdoor daylight PDT can not be performed at all or the effect can not be calculated and is not reproducible. In addition, sunscreen must also be applied. However, the outdoor daylight PDT is considered to be less painful than the conventional red light PDT.
The new medisun PDT 9000 represents the logical further development of the outdoor daylight PDT and the red light PDT.
Medisun PDT 9000 uses programmable multicolor high power LEDs. These can produce many monochromatic and polychromatic light mixtures.
With the newly developed medisun PDT therapy protocol, a painless exposure with an optimized daylight spectrum with only one hour of exposure time is possible, which is just as effective as the conventional red light PDT.
This has now been confirmed by a published clinical study by Prof. Dr. Thomas Dirschka and Prof. Dr. Rolf-Markus Szeimies.
The efficacy and freedom from pain during the exposure was also confirmed by a clinical study by Prof. Dr. med. Hans Michael Ockenfels (Hanau).
The integrated PC control allows different therapy protocols to be used.